0
     

Report Added
Report already added
Global Animal Blood Plasma and Derivatives Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Animal Blood Plasma and Derivatives Market 2022 by Company, Regions, Type and Application, Forecast to 2028

The Animal Blood Plasma and Derivatives market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Animal Blood Plasma and Derivatives market size is estimated to be worth US$ 1027.2 million in 2021 and is forecast to a readjusted size of USD 1379.9 million by 2028 with a CAGR of 4.3% during review period. Food & Beverages accounting for % of the Animal Blood Plasma and Derivatives global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Immunoglobulin segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Animal Blood Plasma and Derivatives include Proliant Inc., Thermo Fisher Scientific, Inc., Merck KGaA, Kraeber & Co GmbH, and LAMPIRE Biological Laboratories, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Animal Blood Plasma and Derivatives market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Immunoglobulin
Fibrinogen
Serum Albumin
Fetal Bovine Serum
Thrombin
New Born Calf Serum
Market segment by Application, can be divided into
Food & Beverages
Pharmaceuticals
Cosmetics
Feed
Others
Market segment by players, this report covers
Proliant Inc.
Thermo Fisher Scientific, Inc.
Merck KGaA
Kraeber & Co GmbH
LAMPIRE Biological Laboratories, Inc.
Lake Immunogenics, Inc.
Rocky Mountain Biologicals Inc.
ANZCO Foods Ltd.
Auckland BioSciences Ltd.
Bovogen Biologicals Pty Ltd.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Animal Blood Plasma and Derivatives product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Animal Blood Plasma and Derivatives, with revenue, gross margin and global market share of Animal Blood Plasma and Derivatives from 2019 to 2022.
Chapter 3, the Animal Blood Plasma and Derivatives competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Animal Blood Plasma and Derivatives market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Animal Blood Plasma and Derivatives research findings and conclusion, appendix and data source.
Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Animal Blood Plasma and Derivatives
1.2 Classification of Animal Blood Plasma and Derivatives by Type
1.2.1 Overview: Global Animal Blood Plasma and Derivatives Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Animal Blood Plasma and Derivatives Revenue Market Share by Type in 2021
1.2.3 Immunoglobulin
1.2.4 Fibrinogen
1.2.5 Serum Albumin
1.2.6 Fetal Bovine Serum
1.2.7 Thrombin
1.2.8 New Born Calf Serum
1.3 Global Animal Blood Plasma and Derivatives Market by Application
1.3.1 Overview: Global Animal Blood Plasma and Derivatives Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Food & Beverages
1.3.3 Pharmaceuticals
1.3.4 Cosmetics
1.3.5 Feed
1.3.6 Others
1.4 Global Animal Blood Plasma and Derivatives Market Size & Forecast
1.5 Global Animal Blood Plasma and Derivatives Market Size and Forecast by Region
1.5.1 Global Animal Blood Plasma and Derivatives Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Animal Blood Plasma and Derivatives Market Size by Region, (2017-2022)
1.5.3 North America Animal Blood Plasma and Derivatives Market Size and Prospect (2017-2028)
1.5.4 Europe Animal Blood Plasma and Derivatives Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Animal Blood Plasma and Derivatives Market Size and Prospect (2017-2028)
1.5.6 South America Animal Blood Plasma and Derivatives Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Animal Blood Plasma and Derivatives Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Animal Blood Plasma and Derivatives Market Drivers
1.6.2 Animal Blood Plasma and Derivatives Market Restraints
1.6.3 Animal Blood Plasma and Derivatives Trends Analysis
2 Company Profiles
2.1 Proliant Inc.
2.1.1 Proliant Inc. Details
2.1.2 Proliant Inc. Major Business
2.1.3 Proliant Inc. Animal Blood Plasma and Derivatives Product and Solutions
2.1.4 Proliant Inc. Animal Blood Plasma and Derivatives Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Proliant Inc. Recent Developments and Future Plans
2.2 Thermo Fisher Scientific, Inc.
2.2.1 Thermo Fisher Scientific, Inc. Details
2.2.2 Thermo Fisher Scientific, Inc. Major Business
2.2.3 Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Product and Solutions
2.2.4 Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
2.3 Merck KGaA
2.3.1 Merck KGaA Details
2.3.2 Merck KGaA Major Business
2.3.3 Merck KGaA Animal Blood Plasma and Derivatives Product and Solutions
2.3.4 Merck KGaA Animal Blood Plasma and Derivatives Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Merck KGaA Recent Developments and Future Plans
2.4 Kraeber & Co GmbH
2.4.1 Kraeber & Co GmbH Details
2.4.2 Kraeber & Co GmbH Major Business
2.4.3 Kraeber & Co GmbH Animal Blood Plasma and Derivatives Product and Solutions
2.4.4 Kraeber & Co GmbH Animal Blood Plasma and Derivatives Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Kraeber & Co GmbH Recent Developments and Future Plans
2.5 LAMPIRE Biological Laboratories, Inc.
2.5.1 LAMPIRE Biological Laboratories, Inc. Details
2.5.2 LAMPIRE Biological Laboratories, Inc. Major Business
2.5.3 LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Product and Solutions
2.5.4 LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 LAMPIRE Biological Laboratories, Inc. Recent Developments and Future Plans
2.6 Lake Immunogenics, Inc.
2.6.1 Lake Immunogenics, Inc. Details
2.6.2 Lake Immunogenics, Inc. Major Business
2.6.3 Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Product and Solutions
2.6.4 Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Lake Immunogenics, Inc. Recent Developments and Future Plans
2.7 Rocky Mountain Biologicals Inc.
2.7.1 Rocky Mountain Biologicals Inc. Details
2.7.2 Rocky Mountain Biologicals Inc. Major Business
2.7.3 Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Product and Solutions
2.7.4 Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Rocky Mountain Biologicals Inc. Recent Developments and Future Plans
2.8 ANZCO Foods Ltd.
2.8.1 ANZCO Foods Ltd. Details
2.8.2 ANZCO Foods Ltd. Major Business
2.8.3 ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Product and Solutions
2.8.4 ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 ANZCO Foods Ltd. Recent Developments and Future Plans
2.9 Auckland BioSciences Ltd.
2.9.1 Auckland BioSciences Ltd. Details
2.9.2 Auckland BioSciences Ltd. Major Business
2.9.3 Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Product and Solutions
2.9.4 Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Auckland BioSciences Ltd. Recent Developments and Future Plans
2.10 Bovogen Biologicals Pty Ltd.
2.10.1 Bovogen Biologicals Pty Ltd. Details
2.10.2 Bovogen Biologicals Pty Ltd. Major Business
2.10.3 Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Product and Solutions
2.10.4 Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Bovogen Biologicals Pty Ltd. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Animal Blood Plasma and Derivatives Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Animal Blood Plasma and Derivatives Players Market Share in 2021
3.2.2 Top 10 Animal Blood Plasma and Derivatives Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Animal Blood Plasma and Derivatives Players Head Office, Products and Services Provided
3.4 Animal Blood Plasma and Derivatives Mergers & Acquisitions
3.5 Animal Blood Plasma and Derivatives New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Animal Blood Plasma and Derivatives Revenue and Market Share by Type (2017-2022)
4.2 Global Animal Blood Plasma and Derivatives Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Animal Blood Plasma and Derivatives Revenue Market Share by Application (2017-2022)
5.2 Global Animal Blood Plasma and Derivatives Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Animal Blood Plasma and Derivatives Revenue by Type (2017-2028)
6.2 North America Animal Blood Plasma and Derivatives Revenue by Application (2017-2028)
6.3 North America Animal Blood Plasma and Derivatives Market Size by Country
6.3.1 North America Animal Blood Plasma and Derivatives Revenue by Country (2017-2028)
6.3.2 United States Animal Blood Plasma and Derivatives Market Size and Forecast (2017-2028)
6.3.3 Canada Animal Blood Plasma and Derivatives Market Size and Forecast (2017-2028)
6.3.4 Mexico Animal Blood Plasma and Derivatives Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Animal Blood Plasma and Derivatives Revenue by Type (2017-2028)
7.2 Europe Animal Blood Plasma and Derivatives Revenue by Application (2017-2028)
7.3 Europe Animal Blood Plasma and Derivatives Market Size by Country
7.3.1 Europe Animal Blood Plasma and Derivatives Revenue by Country (2017-2028)
7.3.2 Germany Animal Blood Plasma and Derivatives Market Size and Forecast (2017-2028)
7.3.3 France Animal Blood Plasma and Derivatives Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Animal Blood Plasma and Derivatives Market Size and Forecast (2017-2028)
7.3.5 Russia Animal Blood Plasma and Derivatives Market Size and Forecast (2017-2028)
7.3.6 Italy Animal Blood Plasma and Derivatives Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Animal Blood Plasma and Derivatives Revenue by Type (2017-2028)
8.2 Asia-Pacific Animal Blood Plasma and Derivatives Revenue by Application (2017-2028)
8.3 Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Region
8.3.1 Asia-Pacific Animal Blood Plasma and Derivatives Revenue by Region (2017-2028)
8.3.2 China Animal Blood Plasma and Derivatives Market Size and Forecast (2017-2028)
8.3.3 Japan Animal Blood Plasma and Derivatives Market Size and Forecast (2017-2028)
8.3.4 South Korea Animal Blood Plasma and Derivatives Market Size and Forecast (2017-2028)
8.3.5 India Animal Blood Plasma and Derivatives Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Animal Blood Plasma and Derivatives Market Size and Forecast (2017-2028)
8.3.7 Australia Animal Blood Plasma and Derivatives Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Animal Blood Plasma and Derivatives Revenue by Type (2017-2028)
9.2 South America Animal Blood Plasma and Derivatives Revenue by Application (2017-2028)
9.3 South America Animal Blood Plasma and Derivatives Market Size by Country
9.3.1 South America Animal Blood Plasma and Derivatives Revenue by Country (2017-2028)
9.3.2 Brazil Animal Blood Plasma and Derivatives Market Size and Forecast (2017-2028)
9.3.3 Argentina Animal Blood Plasma and Derivatives Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Animal Blood Plasma and Derivatives Revenue by Type (2017-2028)
10.2 Middle East & Africa Animal Blood Plasma and Derivatives Revenue by Application (2017-2028)
10.3 Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Country
10.3.1 Middle East & Africa Animal Blood Plasma and Derivatives Revenue by Country (2017-2028)
10.3.2 Turkey Animal Blood Plasma and Derivatives Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Animal Blood Plasma and Derivatives Market Size and Forecast (2017-2028)
10.3.4 UAE Animal Blood Plasma and Derivatives Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Animal Blood Plasma and Derivatives Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Animal Blood Plasma and Derivatives Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Animal Blood Plasma and Derivatives Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Animal Blood Plasma and Derivatives Revenue (USD Million) by Region (2017-2022)
Table 5. Global Animal Blood Plasma and Derivatives Revenue Market Share by Region (2023-2028)
Table 6. Proliant Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Proliant Inc. Major Business
Table 8. Proliant Inc. Animal Blood Plasma and Derivatives Product and Solutions
Table 9. Proliant Inc. Animal Blood Plasma and Derivatives Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Thermo Fisher Scientific, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific, Inc. Major Business
Table 12. Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Product and Solutions
Table 13. Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Merck KGaA Corporate Information, Head Office, and Major Competitors
Table 15. Merck KGaA Major Business
Table 16. Merck KGaA Animal Blood Plasma and Derivatives Product and Solutions
Table 17. Merck KGaA Animal Blood Plasma and Derivatives Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Kraeber & Co GmbH Corporate Information, Head Office, and Major Competitors
Table 19. Kraeber & Co GmbH Major Business
Table 20. Kraeber & Co GmbH Animal Blood Plasma and Derivatives Product and Solutions
Table 21. Kraeber & Co GmbH Animal Blood Plasma and Derivatives Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. LAMPIRE Biological Laboratories, Inc. Corporate Information, Head Office, and Major Competitors
Table 23. LAMPIRE Biological Laboratories, Inc. Major Business
Table 24. LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Product and Solutions
Table 25. LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Lake Immunogenics, Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Lake Immunogenics, Inc. Major Business
Table 28. Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Product and Solutions
Table 29. Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Rocky Mountain Biologicals Inc. Corporate Information, Head Office, and Major Competitors
Table 31. Rocky Mountain Biologicals Inc. Major Business
Table 32. Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Product and Solutions
Table 33. Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. ANZCO Foods Ltd. Corporate Information, Head Office, and Major Competitors
Table 35. ANZCO Foods Ltd. Major Business
Table 36. ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Product and Solutions
Table 37. ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Auckland BioSciences Ltd. Corporate Information, Head Office, and Major Competitors
Table 39. Auckland BioSciences Ltd. Major Business
Table 40. Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Product and Solutions
Table 41. Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Bovogen Biologicals Pty Ltd. Corporate Information, Head Office, and Major Competitors
Table 43. Bovogen Biologicals Pty Ltd. Major Business
Table 44. Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Product and Solutions
Table 45. Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Animal Blood Plasma and Derivatives Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Animal Blood Plasma and Derivatives Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Animal Blood Plasma and Derivatives by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Animal Blood Plasma and Derivatives Players Head Office, Products and Services Provided
Table 50. Animal Blood Plasma and Derivatives Mergers & Acquisitions in the Past Five Years
Table 51. Animal Blood Plasma and Derivatives New Entrants and Expansion Plans
Table 52. Global Animal Blood Plasma and Derivatives Revenue (USD Million) by Type (2017-2022)
Table 53. Global Animal Blood Plasma and Derivatives Revenue Share by Type (2017-2022)
Table 54. Global Animal Blood Plasma and Derivatives Revenue Forecast by Type (2023-2028)
Table 55. Global Animal Blood Plasma and Derivatives Revenue by Application (2017-2022)
Table 56. Global Animal Blood Plasma and Derivatives Revenue Forecast by Application (2023-2028)
Table 57. North America Animal Blood Plasma and Derivatives Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Animal Blood Plasma and Derivatives Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Animal Blood Plasma and Derivatives Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Animal Blood Plasma and Derivatives Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Animal Blood Plasma and Derivatives Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Animal Blood Plasma and Derivatives Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Animal Blood Plasma and Derivatives Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Animal Blood Plasma and Derivatives Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Animal Blood Plasma and Derivatives Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Animal Blood Plasma and Derivatives Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Animal Blood Plasma and Derivatives Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Animal Blood Plasma and Derivatives Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Animal Blood Plasma and Derivatives Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Animal Blood Plasma and Derivatives Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Animal Blood Plasma and Derivatives Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Animal Blood Plasma and Derivatives Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Animal Blood Plasma and Derivatives Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Animal Blood Plasma and Derivatives Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Animal Blood Plasma and Derivatives Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Animal Blood Plasma and Derivatives Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Animal Blood Plasma and Derivatives Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Animal Blood Plasma and Derivatives Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Animal Blood Plasma and Derivatives Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Animal Blood Plasma and Derivatives Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Animal Blood Plasma and Derivatives Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Animal Blood Plasma and Derivatives Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Animal Blood Plasma and Derivatives Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Animal Blood Plasma and Derivatives Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Animal Blood Plasma and Derivatives Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Animal Blood Plasma and Derivatives Revenue by Country (2023-2028) & (USD Million)

List of Figures
Figure 1. Animal Blood Plasma and Derivatives Picture
Figure 2. Global Animal Blood Plasma and Derivatives Revenue Market Share by Type in 2021
Figure 3. Immunoglobulin
Figure 4. Fibrinogen
Figure 5. Serum Albumin
Figure 6. Fetal Bovine Serum
Figure 7. Thrombin
Figure 8. New Born Calf Serum
Figure 9. Animal Blood Plasma and Derivatives Revenue Market Share by Application in 2021
Figure 10. Food & Beverages Picture
Figure 11. Pharmaceuticals Picture
Figure 12. Cosmetics Picture
Figure 13. Feed Picture
Figure 14. Others Picture
Figure 15. Global Animal Blood Plasma and Derivatives Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 16. Global Animal Blood Plasma and Derivatives Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Animal Blood Plasma and Derivatives Revenue Market Share by Region (2017-2028)
Figure 18. Global Animal Blood Plasma and Derivatives Revenue Market Share by Region in 2021
Figure 19. North America Animal Blood Plasma and Derivatives Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Europe Animal Blood Plasma and Derivatives Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Asia-Pacific Animal Blood Plasma and Derivatives Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. South America Animal Blood Plasma and Derivatives Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Middle East and Africa Animal Blood Plasma and Derivatives Revenue (USD Million) and Growth Rate (2017-2028)
Figure 24. Animal Blood Plasma and Derivatives Market Drivers
Figure 25. Animal Blood Plasma and Derivatives Market Restraints
Figure 26. Animal Blood Plasma and Derivatives Market Trends
Figure 27. Proliant Inc. Recent Developments and Future Plans
Figure 28. Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
Figure 29. Merck KGaA Recent Developments and Future Plans
Figure 30. Kraeber & Co GmbH Recent Developments and Future Plans
Figure 31. LAMPIRE Biological Laboratories, Inc. Recent Developments and Future Plans
Figure 32. Lake Immunogenics, Inc. Recent Developments and Future Plans
Figure 33. Rocky Mountain Biologicals Inc. Recent Developments and Future Plans
Figure 34. ANZCO Foods Ltd. Recent Developments and Future Plans
Figure 35. Auckland BioSciences Ltd. Recent Developments and Future Plans
Figure 36. Bovogen Biologicals Pty Ltd. Recent Developments and Future Plans
Figure 37. Global Animal Blood Plasma and Derivatives Revenue Share by Players in 2021
Figure 38. Animal Blood Plasma and Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 39. Global Top 3 Players Animal Blood Plasma and Derivatives Revenue Market Share in 2021
Figure 40. Global Top 10 Players Animal Blood Plasma and Derivatives Revenue Market Share in 2021
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 42. Global Animal Blood Plasma and Derivatives Revenue Share by Type in 2021
Figure 43. Global Animal Blood Plasma and Derivatives Market Share Forecast by Type (2023-2028)
Figure 44. Global Animal Blood Plasma and Derivatives Revenue Share by Application in 2021
Figure 45. Global Animal Blood Plasma and Derivatives Market Share Forecast by Application (2023-2028)
Figure 46. North America Animal Blood Plasma and Derivatives Sales Market Share by Type (2017-2028)
Figure 47. North America Animal Blood Plasma and Derivatives Sales Market Share by Application (2017-2028)
Figure 48. North America Animal Blood Plasma and Derivatives Revenue Market Share by Country (2017-2028)
Figure 49. United States Animal Blood Plasma and Derivatives Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Canada Animal Blood Plasma and Derivatives Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Mexico Animal Blood Plasma and Derivatives Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Europe Animal Blood Plasma and Derivatives Sales Market Share by Type (2017-2028)
Figure 53. Europe Animal Blood Plasma and Derivatives Sales Market Share by Application (2017-2028)
Figure 54. Europe Animal Blood Plasma and Derivatives Revenue Market Share by Country (2017-2028)
Figure 55. Germany Animal Blood Plasma and Derivatives Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. France Animal Blood Plasma and Derivatives Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. United Kingdom Animal Blood Plasma and Derivatives Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Russia Animal Blood Plasma and Derivatives Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Italy Animal Blood Plasma and Derivatives Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Asia-Pacific Animal Blood Plasma and Derivatives Sales Market Share by Type (2017-2028)
Figure 61. Asia-Pacific Animal Blood Plasma and Derivatives Sales Market Share by Application (2017-2028)
Figure 62. Asia-Pacific Animal Blood Plasma and Derivatives Revenue Market Share by Region (2017-2028)
Figure 63. China Animal Blood Plasma and Derivatives Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Animal Blood Plasma and Derivatives Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South Korea Animal Blood Plasma and Derivatives Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Animal Blood Plasma and Derivatives Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Animal Blood Plasma and Derivatives Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Animal Blood Plasma and Derivatives Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Animal Blood Plasma and Derivatives Sales Market Share by Type (2017-2028)
Figure 70. South America Animal Blood Plasma and Derivatives Sales Market Share by Application (2017-2028)
Figure 71. South America Animal Blood Plasma and Derivatives Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Animal Blood Plasma and Derivatives Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Animal Blood Plasma and Derivatives Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East and Africa Animal Blood Plasma and Derivatives Sales Market Share by Type (2017-2028)
Figure 75. Middle East and Africa Animal Blood Plasma and Derivatives Sales Market Share by Application (2017-2028)
Figure 76. Middle East and Africa Animal Blood Plasma and Derivatives Revenue Market Share by Country (2017-2028)
Figure 77. Turkey Animal Blood Plasma and Derivatives Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Animal Blood Plasma and Derivatives Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. UAE Animal Blood Plasma and Derivatives Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source

Report Title: Global Animal Blood Plasma and Derivatives Market 2022 by Company, Regions, Type and Application, Forecast to 2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Global Retinal Surgery Devices Market (By Device Segment, Application, Regional Analysis), Impact of COVID-19, Company Profiles, Major Deals, Strategy and Recent Developments – Forecast to 2027

Global Retinal Surgery Devices Market (By Device Segment, Application, Regional Analysis), Impact of COVID-19, Company Profiles, Major Deals, Strategy and Recent Developments – Forecast to 2027

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028

Animal Wound Care Market by Product (Surgical (Sutures & Staplers, Glues), Advanced (Hydrocolloid, Hydrogel Dressings), Traditional (Tape, Dressings, Bandages), Animal Type (Cats, Dogs, Horse, Pigs), End User (Hospital, Clinics) - Global Forecast to 2027

Animal Wound Care Market by Product (Surgical (Sutures & Staplers, Glues), Advanced (Hydrocolloid, Hydrogel Dressings), Traditional (Tape, Dressings, Bandages), Animal Type (Cats, Dogs, Horse, Pigs), End User (Hospital, Clinics) - Global Forecast to 2027

Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable Scanners), Technology (Contrast, Digital), Animal Type (Small, Large), Application (Gynecology, Cardiology, Orthopedics), End User (Clinics, Hospitals) - Global Forecast to 2027

Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable Scanners), Technology (Contrast, Digital), Animal Type (Small, Large), Application (Gynecology, Cardiology, Orthopedics), End User (Clinics, Hospitals) - Global Forecast to 2027

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027

Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027